Drug Shortage Report for TAPAZOLE
| Report ID | 241872 |
| Drug Identification Number | 02296039 |
| Brand name | TAPAZOLE |
| Common or Proper name | Tapazole 10mg tabs |
| Company Name | PALADIN PHARMA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | METHIMAZOLE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 tabs |
| ATC code | H03BB |
| ATC description | ANTITHYROID PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-10-30 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-11-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
| Company contact information | 1-866-340-1112 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-11-01 | French | Compare |
| v1 | 2024-11-01 | English | Compare |
Showing 1 to 2 of 2